Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (d...
Q2 2026
Aug 3, 2026
Q1 2026
May 4, 2026
FY 2025
Feb 23, 2026
Q4 2025
Q3 2025
Nov 3, 2025
